Utilization of Complementary and Alternative Medicine among Patients with Cardiovascular Disease in Iran: A Cross-Sectional Study
-
Mohammad Hossein Sharifi
,
Salman Mohammadi
,
Naseh Pahlavani
,
Ali Ghaffarian-Bahraman
,
Sara Darabi
,
Mohammad Hossein Nikoo
,
Mohammad Ebrahim Zohalinezhad
Abstract
Complementary Alternative Medicine (CAM) has been widely used globally, but limited data are available on the use of CAM in Cardiovascular Disease (CVD). The present study aimed to evaluate CAM use in CVD patients. The present cross-sectional study was performed in Shiraz, Iran, during the summer of 2021. Cardiovascular patients aged ≥ 18 years were included in the study. Demographic information on left ventricular ejection fraction and satisfaction with CAM utilization was collected using validated questionnaires. A total of 304 patients (194 males and 110 females) were recruited for this study. The frequency of patients identified as CAM users was 56.9% (n = 173). Patients with implanted pacemakers were less likely to use CAM than others (OR = 0.50, p = 0.031). Meanwhile, the likelihood of CAM utilization was approximately 2 and 4 times higher in the patients categorized in class I of the New York Heart Association (NYHA) functional classification compared to those in the second and third classes, respectively. Most CAM users used herbs, dietary supplements, and praying to prevent diseases, while Traditional Persian Medicine (TPM) remedies and acupuncture were more commonly used to treat acute and chronic illnesses, respectively. Praying for health, herbal therapy, and dietary supplementation were the most popular CAM types utilized by Iranian CVD patients. However, future investigations seem to be required to determine the exact physiological impacts, probable adverse effects, and long-term benefits of CAM therapies in this population.
Naghavi M, Abajobir AA, Abbafati C, Abbas KM, Abd-Allah F, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016. Lancet 2017;390:1151-1210.
Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2095-2128.
Roth GA, Abate D, Abate KH, Abay SM, Abbafati C, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1736-1788.
Kyu HH, Abate D, Abate KH, Abay SM, Abbafati C, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1859-1922.
Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, et al. The economic burden of cardiovascular disease and hypertension in low-and middle-income countries: a systematic review. BMC Public Health 2018;18:1-11.
Sarrafzadegan N, Mohammadifard N. Cardiovascular disease in Iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med 2019;22:204-210.
Grant SJ, Bin YS, Kiat H, Chang DH-T. The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health 2012;12:1-9.
Abraham RR. Drug related problems and reactive pharmacist interventions for inpatients receiving cardiovascular drugs. Int J Basic Med Sci Pharm 2013;3:42-48.
Najafpour Boushehri S, Karimbeiki R, Ghasempour S, Ghalishourani SS, Pourmasoumi M, et al. The efficacy of sour tea (Hibiscus sabdariffa L.) on selected cardiovascular disease risk factors: A systematic review and meta‐analysis of randomized clinical trials. Phytother Res 2020;34:329-339.
Prasad K, Prasad A, George M, Sandhu GS, Inojosa JRM, et al. Temporal trends in use of complementary therapies among patients with cardiovascular disorders. Am J Cardiol 2022;167:118-124.
Smith BW, Dalen J, Wiggins KT, Christopher PJ, Bernard JF, et al. Who is willing to use complementary and alternative medicine? Explore 2008;4:359-367.
Bodeker G, Ong C-K. WHO global atlas of traditional, complementary and alternative medicine: World Health Organization 2005.
Jang A, Kang D-H, Kim DU. Complementary and alternative medicine use and its association with emotional status and quality of life in patients with a solid tumor: a cross-sectional study. J Altern Complement Med 2017;23:362-369.
Larijani B, Esfahani MM, Moghimi M, Ardakani MRS, Keshavarz M, et al. Prevention and treatment of flatulence from a traditional Persian medicine perspective. Iran Red Crescent Med J 2016;18:e23644.
Tafazoli V, Tavakoli A, Mosaffa-Jahromi M, Cooley K, Pasalar M. Approach of Persian medicine to health and disease. Advances in Integrative Medicine. 2022;9:3-8.
Shirbeigi L, Zarei A, Naghizadeh A, Vaghasloo MA. The concept of temperaments in traditional Persian medicine. Trad Integr Med 2017;2:143-156.
Zohalinezhad ME, Zarshenas MM. Rhazes and an early case with possible hypertensive or reversible encephalopathy. J Hist Neurosci 2015;24:408-410.
Zohalinezhad ME. Non-pharmacological treatment for heart condition in persian medicine. Adv Integr Med 2019;6:S127-S128.
Che C-T, George V, Ijinu T, Pushpangadan P, Andrae-Marobela K. Traditional medicine. Pharmacognosy: Elsevier 2017; pp 15-30.
Haghani F, Arabnezhad M-R, Mohammadi S, Ghaffarian-Bahraman A. Aloe vera and streptozotocin-induced diabetes mellitus. Rev Bras Farmacogn 2022;32:174-187.
Organization WH. WHO global report on traditional and complementary medicine 2019: World Health Organization 2019.
Zha W. Transporter-mediated natural product–drug interactions for the treatment of cardiovascular diseases.J Food Drug Anal 2018;26:S32-S44.
Shaikh AS, Thomas AB, Chitlange SS. Herb–drug interaction studies of herbs used in treatment of cardiovascular disorders—A narrative review of preclinical and clinical studies. Phytother Res 2020;34:1008-1026.
Bahall M. Complementary and alternative medicine usage among cardiac patients: a descriptive study. BMC Complement Altern Med 2015;15:100.
Ashraf H, Salehi A, Sousani M, Sharifi MH. Use of complementary alternative medicine and the associated factors among patients with depression. Evid Based Complement Altern Med 2021;2021:6626394.
Quandt SA, Verhoef MJ, Arcury TA, Lewith GT, Steinsbekk A, et al. Development of an international questionnaire to measure use of complementary and alternative medicine (I-CAM-Q). J Altern Complement Med 2009;15:331-339.
Ruyvaran M, Salehi A, Fallahzadeh E, Vojoud M, Sharifi MH, et al. Traditional and complementary medicines usage and associated factors in gastrointestinal outpatients in Shiraz, Iran: a cross-sectional survey. Adv Integr Med 2021;8:285-291.
Dolgin M, Dolgin M. The criteria committee of the New York heart association. Nomenclature and criteria for diagnosis of diseases of the heart and great vessels. 1994;253-256.
Unkovic P, Basuray A. Heart failure with recovered EF and heart failure with mid-range EF: current recommendations and controversies. Curr Treat Options Cardiovasc Med 2018;20:1-11.
Sajed H, Sahebkar A, Iranshahi M. Zataria multiflora Boiss. (Shirazi thyme)—An ancient condiment with modern pharmaceutical uses. J Ethnopharmacol 2013;145:686-698.
Nouri M, Farajdokht F, Torbati M, Ranjbar F, Hamedyazdan S, et al. A close look at Echium amoenum processing, neuroactive components, and effects on neuropsychiatric disorders. Galen Med J 2019;8:e1559.
Bhusal KK, Magar SK, Thapa R, Lamsal A, Bhandari S, et al. Nutritional and pharmacological importance of stinging nettle (Urtica dioica L.): A review. Heliyon 2022;e09717.
Samanta S. Potential bioactive components and health promotional benefits of tea (Camellia sinensis). J Am Nutr Assoc 2022;41:65-93.
Saritas SC, Buyukbayram Z, Serin EK, Bilgic Y. Effects of lavender oil intervention before endoscopic retrograde cholangiopancreatography on patients' vital signs, pain and anxiety: A randomized controlled study. Explore 2021;17:446-450.
Silva LCdMA, de Oliveira Mendes FdC, de Castro Teixeira F, de Lima Fernandes TE, Ribeiro KRB, et al. Use of Lavandula angustifolia essential oil as a complementary therapy in adult health care: A scoping review. Heliyon. 2023;14:e15446.
Christiany C, Sudrajat SE, Rahayu I. The potency of Cinnamomum zeylanicum to prevent diseases: a review. Eureka Herba Indonesia 2021;2:49-58.
El Joumaa MM, Borjac JM. Matricaria chamomilla: A valuable insight into recent advances in medicinal uses and pharmacological activities. Phytochem Rev 2022;21:1913-1940.
Noreen S, Tufail T, Badar Ul Ain H, Awuchi CG. Pharmacological, nutraceutical, functional and therapeutic properties of fennel (foeniculum vulgare). Int J Food Prop 2023;26:915-927.
Olaru D, Popa EM. In vitro research on the inhibitory effects of fennel. sage and seabuckthorn essenmtial oils on some food spoilage fungi. Scientific Bulletin Series F Biotechnologies. 2019;23:87-90.
Anka Z, Gimba S, Nanda A, Salisu L. Phytochemistry and pharmacological activities of Foeniculum vulgare. IOSR J Pharm 2020;10:1-10.
Lavanya K. A review on anti-diabetic activity of medicinal spices. Int J Pharm Sci Rev Res 2021;69:72-76.
Świąder K, Startek K, Wijaya CH. The therapeutic properties of Lemon balm (Melissa officinalis L.): Reviewing novel findings and medical indications. J Appl Bot Food Qual 2019;92:327-335.
Alijaniha F, Naseri M, Afsharypuor S, Fallahi F, Noorbala A, et al. Heart palpitation relief with Melissa officinalis leaf extract: double blind, randomized, placebo controlled trial of efficacy and safety. J Ethnopharmacol 2015;164:378-384.
Sadraei H, Ghannadi A, Malekshahi K. Relaxant effect of essential oil of Melissa officinalis and citral on rat ileum contractions. Fitoterapia 2003;74:445-452.
Jafari F, Salehi-Abargouei A, Zare Sakhvidi MJ, Ranjbar AM, Zavar reza J, et al. Comparison of the effects of green tea and Melissa Officinalis on weight and blood pressure in welders: a single-blind, crossover clinical trial. J Nutr Food Secur 2018;3:130-138.
Platel K, Srinivasan K. Digestive stimulant action of spices: a myth or reality? Indian J Med Res 2004;119:167.
Srinivasan K. Ginger rhizomes (Zingiber officinale): a spice with multiple health beneficial potentials. PharmaNutrition 2017;5:18-28.
Akash MSH, Rehman K, Tariq M, Chen S. Zingiber officinale and type 2 diabetes mellitus: evidence from experimental studies. Crit Rev Eukaryot Gene Expr 2015;25:91-112.
Wang C-Z, Qi L-W, Yuan C-S. Cancer chemoprevention effects of ginger and its active constituents: potential for new drug discovery. Am J Chin Med 2015;43:1351-1363.
Poltronieri J, B Becceneri A, M Fuzer A, Cesar C Filho J, Martin CB, et al. [6]-gingerol as a cancer chemopreventive agent: a review of its activity on different steps of the metastatic process. Mini Rev Med Chem 2014;14:313-321.
Bahall M. Complementary and alternative medicine usage among cardiac patients: a descriptive study. BMC complement Altern Med 2015;15:1-8.
Krasuski RA, Michaelis K, Eckart RE. The cardiovascular patient's perceptions of complementary and alternative medicine. Clin Cardiol 2006;29:161-164.
Hunt KJ, Coelho HF, Wider B, Perry R, Hung S, et al. Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract 2010;64:1496-1502.
Bin YS, Kiat H. Prevalence of dietary supplement use in patients with proven or suspected cardiovascular disease. Evid Based Complement Altern Med 2010;2011.
Xue CC, Zhang AL, Lin V, Da Costa C, Story DF. Complementary and alternative medicine use in Australia: a national population-based survey. J Altern Complement Med 2007;13:643-650.
Prasad K, Sharma V, Lackore K, Jenkins SM, Prasad A, et al. Use of complementary therapies in cardiovascular disease. Am J Cardiol 2013;111:339-345.
Nahin RL, Byrd-Clark D, Stussman BJ, Kalyanaraman N. Disease severity is associated with the use of complementary medicine to treat or manage type-2 diabetes: data from the 2002 and 2007 National Health Interview Survey. BMC complement Altern Med 2012;12:1-17.
Morgan W, Center H, Arms-Chavez C, LoBello SG. Complementary and alternative medicine use and asthma: relation to asthma severity and comorbid chronic disease. J Asthma 2014;51:333-338.
Wood MJ, Stewart RL, Merry H, Johnstone DE, Cox JL. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J 2003;145:806-812.
Salah AO, Salameh AD, Bitar MA, Zyoud SeH, Alkaiyat AS, et al. Complementary and alternative medicine use in coronary heart disease patients: a cross-sectional study from Palestine. BMC complement Med Ther 2020;20:1-14.
Anderson JG, Taylor AG. Use of complementary therapies by individuals with or at risk for cardiovascular disease: results of the 2007 National Health Interview Survey. J Cardiovasc Nurs 2012;27:96.
Tachjian A, Maria V, Jahangir A. Use of herbal products and potential interactions in patients with cardiovascular diseases. J Am Coll Cardiol 2010;55:515-525.
Ai AL, Bolling SF. The use of complementary and alternative therapies among middle-aged and older cardiac patients. Am J Med Qual 2002;17:21-27.
Liu EH, Turner LM, Lin SX, Klaus L, Choi LY, et al. Use of alternative medicine by patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 2000;120:335-341.
De Smet PA. The role of plant-derived drugs and herbal medicines in healthcare. Drugs 1997;54:801-840.
| Files | ||
| Issue | Vol 9, No 1, 2024 | |
| Section | Research Article(s) | |
| DOI | https://doi.org/10.18502/tim.v9i1.15085 | |
| Keywords | ||
| Complementary and alternative medicine Traditional Persian medicine Cardiovascular disease NYHA classification Left-ventricular ejection fraction Traditional medicine | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
